• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.

作者信息

Watts Nelson B, Lewiecki E Michael, Bonnick Sydney L, Laster Andrew J, Binkley Neil, Blank Robert D, Geusens Piet P, Miller Paul D, Petak Steven M, Recker Robert R, Saag Kenneth G, Schousboe John, Siris Ethel S, Bilezikian John P

机构信息

University of Cincinnati Bone Health and Osteoporosis Center, 222 Piedmont Road, Suite 6300, Cincinnati, OH 45219, USA.

出版信息

J Bone Miner Res. 2009 Oct;24(10):1643-6. doi: 10.1359/jbmr.090818.

DOI:10.1359/jbmr.090818
PMID:19712042
Abstract
摘要

相似文献

1
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.监测双膦酸盐治疗骨质疏松症患者骨密度的临床价值。
J Bone Miner Res. 2009 Oct;24(10):1643-6. doi: 10.1359/jbmr.090818.
2
[Bisphosphonates: pharmacology and use in the treatment of osteoporosis].双膦酸盐：药理学及在骨质疏松症治疗中的应用
Nihon Rinsho. 2002 Mar;60 Suppl 3:350-8.
3
Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.双膦酸盐对成年男性骨质疏松症的疗效：一项随机对照试验的荟萃分析。
Osteoporos Int. 2015 Sep;26(9):2355-63. doi: 10.1007/s00198-015-3148-4. Epub 2015 May 6.
4
The role of bisphosphonates in the prevention and treatment of osteoporosis.双膦酸盐在骨质疏松症预防和治疗中的作用。
Am J Med. 1993 Nov 30;95(5A):48S-52S. doi: 10.1016/0002-9343(93)90383-z.
5
Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.低能量和高能量骨折后骨密度检测及骨质疏松症管理的患病率
Acta Orthop Traumatol Turc. 2013;47(5):318-22. doi: 10.3944/aott.2013.3065.
6
[Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].监测双膦酸盐治疗时，骨密度测量是必要的。
Clin Calcium. 2011 Jan;21(1):116-9.
7
Issues in designing and testing a "cure" for osteoporosis.
J Musculoskelet Neuronal Interact. 2004 Dec;4(4):408.
8
Pitfalls in the hunt for osteoporosis.骨质疏松症筛查中的陷阱
Am J Med. 2003 Sep;115(4):322-3. doi: 10.1016/s0002-9343(03)00401-7.
9
[Drugs in development for the treatment of osteoporosis: Incadronate].[正在研发的用于治疗骨质疏松症的药物：因卡膦酸盐]
Nihon Rinsho. 2002 Mar;60 Suppl 3:538-43.
10
Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.肾移植后骨密度的变化：法国队列的 2 年评估。
Osteoporos Int. 2018 May;29(5):1165-1175. doi: 10.1007/s00198-018-4383-2. Epub 2018 Mar 2.

引用本文的文献

1
The Use of Bone Density Scan in Monitoring Treatment Response in Patients Diagnosed with Osteoporosis: A Retrospective Cohort Study.骨密度扫描在监测骨质疏松症患者治疗反应中的应用：一项回顾性队列研究。
Int J Rheumatol. 2023 Oct 23;2023:2160346. doi: 10.1155/2023/2160346. eCollection 2023.
2
Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study.绝经后骨质疏松症女性对阿仑膦酸钠治疗反应的骨基因组谱影响：一项回顾性队列研究。
Genes (Basel). 2023 Feb 19;14(2):524. doi: 10.3390/genes14020524.
3
Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial.
海洋 n-3 多不饱和脂肪酸和肾移植受者的骨矿物质密度：一项随机、安慰剂对照试验。
Nutrients. 2021 Jul 10;13(7):2361. doi: 10.3390/nu13072361.
4
Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy.使用机器学习预测骨质疏松症治疗后的骨密度反应，以辅助个性化治疗。
Sci Rep. 2021 Jul 5;11(1):13811. doi: 10.1038/s41598-021-93152-5.
5
The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.印度骨矿研究学会（ISBMR）关于成年人骨质疏松症的诊断和治疗立场声明。
Arch Osteoporos. 2021 Jun 26;16(1):102. doi: 10.1007/s11657-021-00954-1.
6
Factors associated with inadequate responses to risedronate in Japanese patients with osteoporosis.与日本骨质疏松症患者对利塞膦酸钠反应不足相关的因素。
J Bone Miner Metab. 2019 Jan;37(1):185-197. doi: 10.1007/s00774-018-0931-2. Epub 2018 May 8.
7
Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.股骨感兴趣区域的骨密度平均值受与年龄相关的骨几何变化的影响。
Osteoporos Int. 2018 Jun;29(6):1419-1425. doi: 10.1007/s00198-018-4461-5. Epub 2018 Mar 5.
8
Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study.再次进行骨矿物质密度测定的发生率和预测因素：一项纵向队列研究。
J Gen Intern Med. 2017 Oct;32(10):1090-1096. doi: 10.1007/s11606-017-4094-y. Epub 2017 Jun 20.
9
Fracture prediction from repeat BMD measurements in clinical practice.临床实践中通过重复骨密度测量进行骨折预测。
Osteoporos Int. 2016 Jan;27(1):203-10. doi: 10.1007/s00198-015-3259-y. Epub 2015 Aug 5.
10
Associations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries.2007年医疗保险对骨密度检测报销费用的削减与老年医疗保险女性受益人的骨质疏松药物治疗模式之间的关联。
Patient Prefer Adherence. 2014 Jun 25;8:909-15. doi: 10.2147/PPA.S62780. eCollection 2014.